Month: February 2021

Crystal Bay, Nevada, Feb. 08, 2021 (GLOBE NEWSWIRE) — Evo Acquisition Corp. (the “Company”) announced today that it priced its upsized initial public offering of 10,870,000 units, at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will begin trading tomorrow, Tuesday, February 9, 2021, under the ticker symbol “EVOJU.” Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants...

NEW YORK, Feb. 08, 2021 (GLOBE NEWSWIRE) — Spartan Acquisition Corp. III (the “Company”) announced today the pricing of its initial public offering (the “IPO”) of 48,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “SPAQ.U” beginning on February 9, 2021. Each unit consists of one share of the Company’s Class A common stock and one-fourth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of the Company’s Class A common stock at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on the NYSE under the symbols “SPAQ” and “SPAQ.WS,” respectively. The offering is...

COLUMBUS, Ohio, Feb. 08, 2021 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, today announced it plans to host a conference call to discuss results for the fourth quarter and fiscal year 2020 on Thursday, February 25, 2021, at 5:00 p.m. Eastern Time. The Company plans to release its fourth quarter and fiscal year 2020 results in the investor relations section of its website at ir.joinroot.com after the close of the financial markets on February 25, 2021.Webcast and Conference Call DetailsA replay of the webcast will be made available for 30 days after the call on the Investor Relations page of the Company’s website at ir.joinroot.com.About Root, Inc.Root, Inc. is the parent company of Root Insurance Company. Root is a technology company revolutionizing personal insurance with a pricing...

COLMAR, Pa., Feb. 08, 2021 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ:DORM) today announced the Company will report its financial results for the fourth quarter ended December 26, 2020 before the opening of the Nasdaq Stock Market on February 22, 2021.About Dorman ProductsAt Dorman we give repair professionals and vehicle owners greater freedom to fix cars and trucks by focusing on solutions first. For over 100 years, we have been one of the automotive aftermarket’s pioneering problem solvers, releasing tens of thousands of replacement products engineered to save time and money and increase convenience and reliability.Founded and headquartered in the United States, we are a global organization offering more than 80,000 distinct parts, covering both light-duty and heavy-duty vehicles, from chassis...

Changement électif de la monnaie de présentation en dollars américains en date du 31 décembre 2020Le bénéfice par action dilué (« BPA dilué ») lié aux activités poursuivies du quatrième trimestre de 0,91 $ (1,18 $ CA) est en hausse par rapport à 0,70 $ (0,92 $ CA) au quatrième trimestre de 2019, tandis que le BPA ajusté dilué1de 0,98 $ (1,27 $ CA) a augmenté par rapport à 0,72 $ (0,95 $ CA) au quatrième trimestre de l’année précédenteLe bénéfice opérationnel lié aux activités poursuivies du quatrième trimestre s’est établi à 117,1 M$, en hausse par rapport à 92,8 M$ au quatrième trimestre de 2019Les flux de trésorerie nets liés aux activités opérationnelles poursuivies du quatrième trimestre de 164,9 M$, ont augmenté par rapport à 133,3 M$ au quatrième trimestre de 2019Le BPA dilué annuel lié aux activités poursuivies de 3,03 $ (4,06 $ CA)...

TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV) (USA: RVVTF), announces that it has filed a Form 51-102F4 Business Acquisition Report (BAR) pursuant to National Instrument 51-102 Continuous Disclosure Obligations in connection with its acquisition of Psilocin Pharma Corp. on March 5, 2020.‎ The BAR has been filed as a result of a review conducted by staff at the Ontario Securities Commission in connection with the Company’s recently filed preliminary short form prospectus dated January 26, 2021.For more information, please contact:Michael FrankChief Executive OfficerRevive Therapeutics Ltd.Tel: 1 888 901 0036Email: mfrank@revivethera.comWebsite: www.revivethera.com 

PITTSBURGH, Feb. 08, 2021 (GLOBE NEWSWIRE) — II‐VI Incorporated (Nasdaq: IIVI), a leading provider of semiconductor lasers and micro-optics for consumer electronics, today announced its double-junction vertical cavity surface-emitting laser (VCSEL) arrays, the first of its multi-junction VCSEL array platforms for next-generation world-facing 3D sensing applications.The growing adoption of 3D sensing in several markets, including in consumer electronics, automotive, and industrial, is driving the demand for depth sensors with longer and wider range, lower power consumption, smaller size, and lower cost. II-VI’s new VCSEL arrays are based on a double-junction technology that doubles the power output per VCSEL emitter and improves the power conversion efficiency to 56%, compared with 46% in existing single-junction technology. This...

TORONTO, Feb. 08, 2021 (GLOBE NEWSWIRE) — Kuuhubb Inc. (“Kuuhubb” or the “Company”) (TSX- V: KUU), a mobile game development and publishing company focused on providing the female audience with creative interactive gaming experiences, announces that, further to its news releases dated August 19, 2020 and November 30, 2020, it has entered into an agreement with Cherrypick Games S.A. (“Cherrypick”) to amend (the “Amendment”) the settlement terms to the settlement agreement (the “Settlement Agreement”) relating to the acquisition of the My Hospital application from Cherrypick. Pursuant to the Amendment, Kuuhubb shall pay to Cherrypick: (i) €100,000 (approximately CAD$153,700) on or before February 7, 2021 and €150,000 (approximately CAD$230,550) on or before February 15, 2021, which payments replace and supersede the second payment...

SEATTLE, Feb. 08, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the closing of its upsized initial public offering of 27,025,000 shares of its common stock at a public offering price of $25.00 per share, which includes the full exercise by the underwriters of their option to purchase 3,525,000 additional shares of common stock. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sana, were approximately $675.6 million. All of the shares of common stock were offered by Sana. Sana’s common stock is listed on The Nasdaq Global Select Market under the ticker symbol “SANA.”Morgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan and BofA...